UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.26B |
| 2 |
Strategy Inc
MSTR
|
+$745M |
| 3 |
EA
Electronic Arts
EA
|
+$725M |
| 4 |
TotalEnergies
TTE
|
+$639M |
| 5 |
Walmart Inc
WMT
|
+$585M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.87B |
| 2 |
Apple
AAPL
|
+$1.41B |
| 3 |
Microsoft
MSFT
|
+$1.16B |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$1.03B |
| 5 |
Southwest Airlines
LUV
|
+$727M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.52% |
| 2 | Financials | 9.54% |
| 3 | Healthcare | 6.68% |
| 4 | Industrials | 6.61% |
| 5 | Consumer Discretionary | 6.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PFN
5676
PIMCO Income Strategy Fund II
PFN
$698M
| $846K | ﹤0.01% |
112,737
+32,665
| +41% | +$244K |
|
5677
Abeona Therapeutics
ABEO
$341M
| $845K | ﹤0.01% |
160,401
+32,169
| +25% | +$162K |
|
|
ALMU
5678
Aeluma Inc
ALMU
$335M
| $844K | ﹤0.01% |
49,142
+6,415
| +15% | +$101K |
|
5679
CALL
Bath & Body Works
BBWI
$3.91B
| $843K | ﹤0.01% |
+42,000
| New | +$927K |
|
5680
Acrivon Therapeutics
ACRV
$84.7M
| $840K | ﹤0.01% |
348,541
-334,677
| -49% | -$728K |
|
|
PBT
5681
Permian Basin Royalty Trust
PBT
$1.59B
| $838K | ﹤0.01% |
49,370
-98,208
| -67% | -$1.76M |
|
|
CMU
5682
DELISTED
MFS High Yield Municipal Trust
CMU
| $838K | ﹤0.01% |
238,830
-10,523
| -4% | -$36.8K |
|
5683
CNB Financial Corp
CCNE
$1.04B
| $837K | ﹤0.01% |
31,999
+2,375
| +8% | +$60.2K |
|
|
CGO
5684
Calamos Global Total Return Fund
CGO
$130M
| $835K | ﹤0.01% |
73,348
-11,386
| -13% | -$132K |
|
|
FRMM
5685
Forum Markets
FRMM
$80.8M
| $835K | ﹤0.01% |
170,473
+152,629
| +855% | +$2.15M |
|
5686
Finward Bancorp
FNWD
$196M
| $834K | ﹤0.01% |
23,707
+12,307
| +108% | +$433K |
|
|
MMT
5687
Aberdeen Multi-Market Income Fund
MMT
$244M
| $834K | ﹤0.01% |
179,392
-4,018
| -2% | -$18.9K |
|
|
FMN
5688
Federated Hermes Premier Municipal Income Fund
FMN
$87.6M
| $834K | ﹤0.01% |
75,053
+3,178
| +4% | +$35.3K |
|
5689
State Street SPDR MSCI ACWI Climate Paris Aligned ETF
NZAC
$199M
| $833K | ﹤0.01% |
19,416
-495
| -2% | -$21.2K |
|
|
MCTA
5690
Charming Medical Ltd
MCTA
| $829K | ﹤0.01% |
+28,249
| New | +$510K |
|
5691
Invesco S&P SmallCap Value with Momentum ETF
XSVM
$676M
| $827K | ﹤0.01% |
14,468
-1,228
| -8% | -$69.1K |
|
5692
Horizon Bancorp
HBNC
$1.06B
| $826K | ﹤0.01% |
48,681
-24,629
| -34% | -$408K |
|
5693
ProShares UltraShort S&P500
SDS
$366M
| $825K | ﹤0.01% |
12,040
-4,960
| -29% | -$350K |
|
5694
Smith Douglas Homes
SDHC
$121M
| $823K | ﹤0.01% |
49,047
+22,915
| +88% | +$414K |
|
5695
Caesarstone
CSTE
$117M
| $822K | ﹤0.01% |
442,022
+95,571
| +28% | +$134K |
|
|
GLDD
5696
DELISTED
Great Lakes Dredge & Dock
GLDD
| $822K | ﹤0.01% |
62,633
-23,193
| -27% | -$286K |
|
5697
Timothy Plan High Dividend Stock ETF
TPHD
$371M
| $821K | ﹤0.01% |
21,306
-1,411
| -6% | -$54.5K |
|
5698
Community Health Systems
CYH
$424M
| $819K | ﹤0.01% |
262,519
-289,162
| -52% | -$972K |
|
5699
CALL
Zimmer Biomet
ZBH
$19.1B
| $818K | ﹤0.01% |
+9,100
| New | +$863K |
|
|
BFS
5700
Saul Centers
BFS
$865M
| $818K | ﹤0.01% |
25,939
+1,892
| +8% | +$58.1K |
|
Similar funds
UBS Group's Q4 2025 Portfolio in Review
As of Q4 2025, UBS Group held 11,616 positions worth $617B, down 3.4% from $638B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
UBS Group withdrew a net $32.7B in Q4 2025, closing 1,184 positions and reducing 4,502 holdings. Its most notable exit was Kellanova, an estimated $617M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
Against the trend, UBS Group opened a new position in Solstice Advanced Materials worth $130M.
- UBS Group's largest Q4 2025 buy was Solstice Advanced Materials: 2,681,543 shares worth $130M.
- UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $1.26B increase.
- UBS Group's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $1.87B.
- UBS Group fully exited Kellanova in Q4 2025, selling an estimated $617M.
- UBS Group's ten largest holdings make up 15% of its $617B portfolio in Q4 2025.
- UBS Group opened 1,319 new positions and closed 1,184 in Q4 2025.
- UBS Group's portfolio value fell 3.4% quarter-over-quarter to $617B.
Based on UBS Group's 13F filing for Q4 2025, filed 29 Jan 2026.